The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
- 31 December 1995
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 173 (6), 1849-1854
- https://doi.org/10.1016/0002-9378(95)90439-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Thrombosis and hormone replacement therapy in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1993
- Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal WomenNew England Journal of Medicine, 1993
- Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapyBritish Journal of Haematology, 1993
- Menopause, hormone replacement therapy and cardiovascular disease: A review of haemostaseological findingsFibrinolysis, 1992
- Hemostatic factors according to menopausal status and use of hormone replacement therapyAnnals of Epidemiology, 1992
- Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein(a)Thrombosis Research, 1992
- Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal womenThrombosis Research, 1991
- Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Heart, 1988
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986